Non-adrenergic binding of [3H]atipamezole in rat kidney - Regional distribution and comparison to α2-adrenoceptors

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1215-1222

  Sjöholm, Birgitta ^a,b   Lähdesmäki, Janne ^a   Pyykkö, Kaija ^a   Hillilä, Maarit ^a   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Imidazoline receptors; Non adrenergic binding; Rat kidney; Receptor autoradiography; 3H atipamezole; 3H rauwolscine; 3H RX821002; 2 adrenoceptors

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; APRACLONIDINE; ATIPAMEZOLE; IDAZOXAN; IMIDAZOLINE RECEPTOR; RAUWOLSCINE; TRITIUM;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; KIDNEY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032738753     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702917     Document Type: Article

References (51)

1. ALLAN, D.R., PENNER, S.B. & SMYTH, D.D. (1993). Renal imidazoline preferring sites and solute excretion in the rat. Br. J. Pharmacol., 108, 870-875.
2. 3H]Cirazoline as a tool for the characterization of imidazoline sites. Ann. N.Y. Acad. Sci., 763, 112-124.
3. BERDEU, D., GROSS, R., LOUBATIÈRES-MARIANI, M.-M. & BERTRAND, G. (1994). Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas. Eur. J. Pharmacol., 254, 119-125.
4. + transport and intracellular pH in renal proximal tubule cells. Biochim. Biophys. Acta. 1024, 173-178.
5. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. BROWN, C.A., LOWETH, A.C., SMITH, S.A. & MORGAN, N.G. (1993). Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites. Br. J. Pharmacol., 108, 312-317.
7. 2-sites. Br. J. Pharmacol., 112, 1065-1070.
8. COUPRY, I., PODEVIN, R.A., DAUSSE, J.-P. & PARINI, A. (1987). Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem. Biophys. Res. Commun., 147, 1055-1060.
9. 2-adrenoceptor antagonist on guinea-pig submucous neurones. Br. J. Pharmacol., 92, 341-347.
10. DIAMANT, S., ELDAR-GEVA, T. & ATLAS, D. (1992). Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function. Br. J. Pharmacol., 106, 101-108.
11. EGLEN, R.M., HUDSON, A.L., KENDALL, D.A., NUTT, D.J., MORGAN, N.G., WILSON, V.G. & DILLON, M.P. (1998). "Seeing through a glass darkly": casting light on imidazoline "I" sites. Trends Pharmacol. Sci., 19, 381-390.
12. 1-imidazoline sites. J. Pharmacol. Exp. Ther., 264, 172-182.
13. ERNSBERGER, P., FEINLAND, G., MEELEY, M.P. & REIS, D.J. (1990). Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am. J. Hypertens., 3, 90-97.
14. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol., 134, 1-13.
15. 3H]-rauwolscine in the kidney of the dog. Clin. Exp. Pharmacol. Phys., 21, 649-658.
16. 3H]mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptors. Neurochem. Int., 31, 125-129.
17. 3H]RX821002 binding to membranes and tissue sections. Eur. J. Pharmacol., 310, 83-93.
18. 3H]RX821002 as radioligands. Biochim. Biophys. Acta, 1266, 207-214.
19. HALPERT, J.R., GUENGERICH, F.P., BEND, J.R. & CORREIA, M.A. (1994). Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol., 125, 163-175.
20. 2-adrenergic receptors. Mol. Pharmacol., 40, 407-412.
21. KELLER, H.H., KETTLER, R., KELLER, G. & DA PRADA, M. (1987). Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491. Naynun-Schmiedeberg's Arch. Pharmacol., 335, 12-20.
22. 3H]rilmenidine in membranes from rat cerebral cortex. Eur. J. Pharmacol., 218, 101-108.
23. 3H]rilmenidine binding in rat brain and kidney. Ann. N. Y. Acad. Sci., 763, 194-207.
24. KRIZ, W. & BANKER, L. (1988). A standard nomenclature for structures of the kidney. Kidney Int., 33, 1-7.
25. 2-adrenergic binding sites in basolateral membranes from human kidney. Eur. J. Pharmacol - Mol. Pharmacol. Section, 206, 23-31.
26. 2-adrenergic binding sites. Mol. Pharmacol., 37, 876-885.
27. 3H]eirazoline to an imidazoline site in rat brain and kidney membranes. Eur. J. Pharmacol., 278, 261-264.
28. LI, G., REGUNATHAN, R., BARROW, C.J., ESHRAGI, J., COOPER, R. & REIS, D.J. (1994). Agmatine: an endogenous clonidine-displacing substance in the brain. Science, 263, 966-969.
29. 3H]idazoxan label different populations of imidazoline sites on rat kidney. Eur. J. Pharmacol., 232, 79-87.
30. 2-adrenoceptors to characterize subtype selectivity of antagonist binding. Eur. J. Pharmacol. - Mol. Pharmacol. Section, 246, 219-226.
31. MEISTER, B., DAGERLIND, Å., NICHOLAS, A.P. & HÖKFELT, T. (1994). Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney. J. Pharmacol. Exp. Ther., 268, 1605-1611.
32. 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol. Pharmacol., 35, 324-330.
33. MICHEL, M.C. & ERNSBERGER, P. (1992). Keeping an eye on the site: imidazoline preferring receptors. Trends Pharmacol. Sci., 13, 369-370.
34. MICHEL, M.C. & INSEL, P.A. (1989). Are there multiple imidazoline binding sites? Trends Pharmacol. Sci., 10, 342-344.
35. 2 receptors. Eur. J. Pharmacol., 262, 41-48.
36. 3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J. Pharmacol. Exp. Ther., 268, 1362-1367.
37. PARINI, A., MOUDANOS, C.G., PIZZINAT, N. & LANIER, S.M. (1996). The elusive family of imidazoline binding sites. Trends Pharmacol. Sci., 17, 13-16.
38. 3H]Tryptamine binding sites are not identical to monoamine oxidase in rat brain. J. Neurochem., 51, 1535-1540.
39. RADDATZ, R., PARINI, A. & LANIER, S.M. (1995). Identification of imidazoline/guanidinium receptive sites as distinct domains on the enzyme monoamine oxidase: Cell-type specific access to binding domains. J. Biol. Chem., 270, 15269-15270.
40. 2-adrenoceptor agonist, detects a novel imidazole binding site in adult rat spinal cord. Eur. J. Pharmacol., 306, 315-323.
41. 2-adrenoceptor antagonist. Eur. J. Pharmacol., 151, 35-42.
42. 3H]atipamezole in rat kidney. Br. J. Pharmarol., 199, P12.
43. 3H]atipamezole in rat lung: A novel imidazole binding site? Ann. N. Y. Acad. Sci., 763, 66-77.
44. 2-adrenoceptors. Eur. J. Pharmacol., 215, 109-117.
45. 2-adrenoceptors in the rat kidney. Eur. J. Pharmacol., 116, 271-278.
46. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem., 270, 9856-9861.
47. TESSON, F., PRIP-BUUS, C., LEMOINE, A., PEGORIER, J.-P. & PARINI, A. (1991). Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J. Biol. Chem., 266, 155-160.
48. VIGNE, P., LAZDUNSKI, M. & FRELIN, C. (1989). Guanabenz, guanachlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes. Eur. J. Pharmacol., 160, 295-298.
49. 2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther., 297, 190-204.
50. WEYLER, W. & SALACH, J.I. (1985). Purification and properties of mitochondrial monoamine oxidase type A from human placenta. J. Biol. Chem., 26, 155-160.
51. 3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of the receptor. Pharmacol. Toxicol., 70, 208-219.